Human biodistribution and dosimetry of the D2/3 agonist 11C-N-propylnorapomorphine (11C-NPA) determined from PET.
about
Radiation dosimetry and biodistribution of the TSPO ligand 11C-DPA-713 in humansSuggested pathway to assess radiation safety of 11C-labeled PET tracers for first-in-human studies.Agonist high- and low-affinity states of dopamine D₂ receptors: methods of detection and clinical implications.(18)F-MCL-524, an (18)F-Labeled Dopamine D2 and D3 Receptor Agonist Sensitive to Dopamine: A Preliminary PET Study.
P2860
Human biodistribution and dosimetry of the D2/3 agonist 11C-N-propylnorapomorphine (11C-NPA) determined from PET.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 16 April 2009
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Human biodistribution and dosi ...... (11C-NPA) determined from PET.
@en
Human biodistribution and dosimetry of the D2/3 agonist 11C-N-propylnorapomorphine
@nl
type
label
Human biodistribution and dosi ...... (11C-NPA) determined from PET.
@en
Human biodistribution and dosimetry of the D2/3 agonist 11C-N-propylnorapomorphine
@nl
prefLabel
Human biodistribution and dosi ...... (11C-NPA) determined from PET.
@en
Human biodistribution and dosimetry of the D2/3 agonist 11C-N-propylnorapomorphine
@nl
P2093
P2860
P1476
Human biodistribution and dosi ...... (11C-NPA) determined from PET
@en
P2093
Brian J Lopresti
Charles M Laymon
Chester A Mathis
James M Mountz
Jonathan P Carney
Maralee Y Litschge
N Scott Mason
Rajesh Narendran
P2860
P304
P356
10.2967/JNUMED.108.058131
P407
P577
2009-04-16T00:00:00Z